The relationship between high density lipoprotein subclass profile and plasma lipids concentrations

Lipids in Health and Disease

Volumn 9, Issue , 2010, Pages

  Tian, Li ^a,b   Fu, Mingde ^a,b  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; LIPID;

CHOLESTEROL BLOOD LEVEL; DYSLIPIDEMIA; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; LIPID BLOOD LEVEL; MIXED DYSLIPIDEMIA; PARTICLE SIZE; REVIEW; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BLOOD; CLASSIFICATION;

ANIMALS; APOLIPOPROTEIN A-I; CHOLESTEROL, HDL; CHOLESTEROL, LDL; HUMANS; LIPIDS; LIPOPROTEINS, HDL; TRIGLYCERIDES;

EID: 77957914886     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-9-118     Document Type: Review

References (61)

1. Physiological role and clinical relevance of high-density lipoprotein subclasses. A Von Eckardstein Y Huang G Assmann, Curr Opin Lipidol 1994 5 404 416 10.1097/00041433-199412000-00003 7712045
2. Study on the immunodetection method of HDL subclasses in human serum. XW Wu MD Fu BW Liu, Chin J Arterioscler 1999 7 253 255
3. Alterations of HDL subclasses in hyperlipidemia. YH Xu MD Fu, Clin Chim Acta 2003 332 95 102 10.1016/S0009-8981(03)00138-4 12763286
4. Antiatherogenic small, dense HDL-guardian angel of the arterial wall? A Kontush MJ Chapman, Nat Clin Pract Cardiovasc Med 2006 3 144 153 10.1038/ncpcardio0500 16505860
5. High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study. BF Asztalos LA Cupples S Demissie KV Horvath CE Cox MC Batista EJ Schaefer, Arterioscler Thromb Vasc Biol 2004 24 2181 2187 10.1161/01.ATV.0000146325.93749.a8 15388521
6. Altered particle size distribution of apoA-I-containing HDL subpopulations in patients with coronary heart disease. MC Cheung BG Brown AC Wolf, J lipid Res 1991 32 383 394 1906084
7. Overview of plasma lipid transport. KA Rye MA Clay PJ Barter, Plasma lipids and their role in disease Advances in vascular biology. Harwood Academic Publishers imprint, Barter PJ, Rye KA, 1999 1 16 full-text
8. Alterations of HDL subclasses in endogenous hypertriglyceridemia. LT Gou MD Fu YH Xu L Tian BY Yan LC Yang, Am Heart J 2005 150 1039 1045 10.1016/j.ahj.2005.02.032 16290993
9. Alterations of high-density lipoprotein subclasses in hypercholesteromia and combined hyperlipidemia. LQ Jia MD Fu Y Tian YH Xu LT Gou HM Tian L Tian, Int Cardio J 2007 120 331 337 10.1016/j.ijcard.2006.10.007 (Pubitemid 47069558)
10. Alterations of high density lipoprotein subclasses in obese subjects. L Tian LQ Jia MD Fu Y Tian YH Xu HM Tian YY Yang, Lipids 2006 41 789 796 10.1007/s11745-006-5032-7 17120933
11. Relationship between total cholesterol/high-density lipoprotein cholesterol ratio, triglyceride/high-density lipoprotein cholesterol ratio, and high-density lipoprotein subclasses. LQ Jia SY Long MD Fu BY Yan Y Tian YH Xu LT Gou, Metabolism 2006 55 1141 1148 10.1016/j.metabol.2006.04.004 16919530
12. Association of low density lipoprotein cholesterol/high density lipoprotein cholesterol ratio and concentrations of plasma lipids with high-density lipoprotein subclass distribution in Chinese population. L Tian YH Liu Y Qin SY Long YH Xu MD Fu, Lipids in Health and Disease 2010 9 69 10.1186/1476-511X-9-69 20615262
13. Relationship between apolipoproteins and the alteration of HDL subclasses in hyperlipidemic subjects. LQ Jia XW Wu MD Fu YH Xu Y Tian HM Tian L Tian, Clin Chim Acta 2007 383 65 72 10.1016/j.cca.2007.04.017 17532312
14. Relationship between plasma HDL subclasses distribution and lipoprotein lipase gene HindIII polymorphism in hyperlipidemia. SY Long Y Tian R Zhang LC Yang YH Xu LQ Jia MD Fu, Clin Chim Acta 2006 366 316 321 10.1016/j.cca.2005.11. 010 16364275
15. Relationship between plasma lipid concentrations and HDL subclasses. YY Yang BY Yan MD Fu YH Xu Y Tian, Clinica Chimica Acta 2005 354 49 58 10.1016/j.cccn.2004.11.015 (Pubitemid 40320673)
16. Relationship between apolipoprotein concentrations and HDL subclasses distribution. L Tian MD Fu LQ Jia YH Xu SY Long HM Tian Y Tian, Lipids 2007 42 419 426 10.1007/s11745-007-3031-y 17476546 (Pubitemid 46870360)
17. Relationship between apolipoprotein C-III concentrations and high-density lipoprotein subclass distribution. L Tian J Wu MD Fu YH Xu LQ Jia, Metabolism 2009 58 668 674 10.1016/j.metabol.2009.01.007 19375590
18. The influence of plasma apoCII concentrations on HDL subclasses distribution. L Tian YH Xu MD Fu LQ Jia YY Yang, J Atherosclerosis Thromb 2009 16 611 620
19. Relationship between plasma apolipoproteinB concentrations, apolipoproteinB/apolipoproteinA-I and HDL subclasses distribution. L Tian XW Wu MD Fu Y Qin YH Xu LQ Jia, Clin Chim Acta 2008 388 148 155 10.1016/j.cca.2007.10. 028 18036560
20. The influence of plasma apolipoproteinA-II concentrations on HDL subclasses distribution. L Tian XW Wu MD Fu YH Xu LQ Jia, Eur J Lipid Sci Technol 2008 110 879 886 10.1002/ejlt.200700281
21. High-density lipoprotein subclasses distribution and composition in Mexican adolescents with low HDL cholesterol and/or high triglyceride concentrations, and its association with insulin and C-reactive protein. A Medina-Urrutia JG Juarez-Rojas R Martnez-Alvarado E Jorge-Galarza R Posadas-Snchez G Cardoso-Saldaa N Caracas-Portilla E Mendoza-Perez C Posadas-Romero, Atherosclerosis 2008 201 392 397 10.1016/j.atherosclerosis.2008. 02.029 18420210
22. Study on the pathogenesis of endogenous hypoertriglyceridemia. BW Liu, Chin J Arterioscler 1993 1 67 69
23. Hypertriglyceridemia and cardiovascular risk reduction. TA Jacobson M Miller EJ Schaefer, Clinical Therapeutics 2007 29 763 777 10.1016/j.clinthera. 2007.05.002 17697898
24. Triglycerides and the Risk of Coronary Heart Disease 10158 Incident Cases Among 262525 Participants in 29 Western Prospective Studies. N Sarwar J Danesh G Eiriksdottir G Sigurdsson N Wareham S Bingham S Matthijs Boekholdt KT Khaw V Gudnason, Circulation 2007 115 450 458 10.1161/CIRCULATIONAHA.106.637793 17190864
25. 1-HDL concentrations. T Miida K Inanom T Yamaguchi T Tsuda M Okada, Atherosclerosis 1997 133 221 226 10.1016/S0021-9150(97)00133-0 9298682
26. Reduction in the incidence of coronary heart disease. Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial results. I, JAMA 1984 251 351 364 10.1001/jama.251.3.351 6361299
27. Carbohydrate restriction alters lipoprotein metabolism by modifying VLDL, LDL, and HDL subfraction distribution and size in overweight men. RJ Wood JS Volek Y Liu NS Shachter JH Contois ML Fernandez, J Nutr 2006 136 384 389 16424116
28. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adults Treatment Panel III). JAMA 2001 285 2486 2497 10.1001/jama.285.19.2486 11368702
29. Studies on the plasma lipid profiles, and LCAT and CETP activities according to hyperlipoproteinemia phenotypes (HLP). M Lee JQ Kim J Kim H Oh M Park, Atherosclerosis 2001 159 381 389 10.1016/S0021-9150(01)00513-5 11730818
30. Lipoprotein subpopulation distributions in Lean, Obese and Type 2 Diabetic Women: A comparison of African and White Americans. PS MacLean JF Bower S Vadlamudi T Green HA Barakat, Obesity Research 2000 8 62 70 10.1038/oby.2000.9 10678260
31. Remodeling of high density lipoproteins by plasma factors. KA Rye MA Clay PJ Barter, Atherosclerosis 1999 145 227 238 10.1016/S0021-9150(99)00150-1 10488948
32. Sialic acid content of LDL and lipoprotein metabolism in combined hyperlipidemia and primary moderate hypercholesterolemia. N Lindbohm H Gylling TE Miettinen TA Miettinen, Clin Chim Acta 1999 285 69 84 10.1016/S0009-8981(99) 00107-2 10481924
33. Interrelationships between postprandial lipoprotein B:CIII particle changes and high-density lipoprotein subpopulation profiles in mixed hyperlipoproteinemia. Y Saidi D Sich A Camproux M Egloff MC Federspiel v Cautier A Raisonnier G Turpin I Beucler, Metabolism 1998 48 60 67 10.1016/S0026- 0495(99)90011-2
34. Association of heterozygous familial hypercholesterolemia with smaller HDL particle size. JC Hogue B Lamarche D Gaudet AJ Tremblay JP Després J Bergeron C Gaqné P Couture, Atherosclerosis 2007 190 429 435 10.1016/j.atherosclerosis.2006.02.023 16546193
35. Prediction of coronary heart disease using risk factor categories. PW Wilson RB D'Agostino D Levy AM Belanger H Silbershatz WB Kannel, Circulation 1998 97 1837 1847 9603539
36. Starting early to control all risk factors in order to prevent coronary heart disease. HC McGill CA McMahan, Clinical Lipidology 2010 5 87 93 10.2217/clp.09.82
37. Lipases and lecithin:cholesterol acyltransferase in the control of lipoprotein metabolism. D Applebaun-Bowden, Curr Opin Lipidol 1995 6 130 135 10.1097/00041433-199506000-00004 7648001
38. Is the Cholesteryl ester transfer protein proatherogenic or antiatherogenic in humans? M Cuchel DJ Rader, J Am Coll Cardiol 2007 50 1956 1958 10.1016/j.jacc.2007.07.059 17996560
39. Enhanced cholesteryl ester transfer protein activities and abnormalities of high density lipoproteins in familial hypercholesterolemia. A Inazu J Koizumi H Mabuchi K Kajinami R Takeda, Horm Metab Res 1992 4 284 288 10.1055/s-2007-1003314
40. Regulation of the concentration of pre high-density lipoprotein in normal plasma by cell membranes and lecithin:cholesterol acyltransferase activity. T Miida M Kawano CJ Fielding PE Fielding, Biochemistry 1992 31 11112 11117 10.1021/bi00160a022 1445850
41. Fasting triglycerides, high density lipoprotein, and risk of myocardial infarction. JM Gaziano CH Hennekens CJ O'Donnell JL Breslow JE Buring, Circulation 1997 96 2520 2525 9355888
42. NIH Consensus Conference: Triglyceride, High-Density Lipoprotein, and Coronary Heart Disease. NIH Consensus Development Panel on Triglyceride, High-Density Lipoprotein, and Coronary Heart Disease, JAMA 1993 269 505 510 10.1001/jama.269.4.505 8419671
43. High ratio of triglycerides to HDL-Cholesterol predicts extensive coronary disease. PL Da Luz D Favarato JR Faria-Neto P Lemos AC Chagas, Clinics 2008 63 427 432 18719750
44. Beyond low-density lipoprotein cholesterol. Respective contributions of Non-high-Density Lipoprotein Cholesterol Levels, Triglycerides, and the Total cholesterol/High-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women. BJ Arsenault JS Rana ESG Stroes JP Després PK Shah JJP Kastelein NJ Wareham S Matthijs Boekholdt KT Khaw, J Am Coll Cardiol 2010 55 35 41 10.1016/j.jacc.2009.07.057
45. Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham Study. WP Castelli RJ Garrison PWF Wilson RD Abbott S Kalousdian WB Kannel, JAMA 1986 256 2835 2838 10.1001/jama.256.20.2835 3773200
46. High-density lipoprotein subfractions and risk of coronary artery disease. J Morgan C Carey A Lincoff D Capuzzi, Current Atherosclerosis Reports 2004 6 359 365 10.1007/s11883-004-0047-0 15296702
47. Low high-density lipoprotein cholesterol:an important consideration in coronary heart disease risk assessment. M Farhan M Michael, Current Opinion in Endocrinology, Diabetes & Obesity 2008 15 175 181
48. Non-HDL cholesterol, apolipoproteinA-I and B100, Standard Lipid Measures, Lipid Ratios, and CRP as Risk Factors for Cardiovascular Disease in Women. PM Ridker N Rifai NR Cook G Bradwin JE Buring, JAMA 2005 294 326 333 10.1001/jama.294.3.326 16030277
49. A prospective study of cholesterol apolipoproteins and the risk of myocardial infarction. MJ Stampfer FM Sacks S Salvini WC Willett CH Hennekens, N Engl J Med 1991 325 373 381 10.1056/NEJM199108083250601 2062328
50. Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men. I Lemieux B Lamarche C Couillard A Pascot B Cantin J Bergeron GR Dagenais JP Desprès, Arch Intern Med 2001 161 2685 2692 10.1001/archinte.161.22.2685 11732933
51. Summary estimates of cholesterol used to predict coronary heart disease. WP Castelli RD Abbott PM McNamara, Circulation 1983 67 730 734 6825228
52. Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation and atherosclerosis. A Kontush MJ Chapman, Pharmacol Rev 2006 58 342 374 10.1124/pr.58.3.1 16968945
53. Molecular regulation of HDL metabolism and function: implications for novel therapies. DJ Rader, J Clin Invest 2006 116 3090 3100 10.1172/JCI30163 17143322
54. High-Density Lipoprotein as a Therapeutic Target. IM Singh MH Shishehbor BJ Ansell, JAMA 2007 298 786 798 10.1001/jama.298.7.786 17699012
55. Oral administration of an apo A-I mimetic peptide synthesized from Damino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol. M Navab GM Anantharamaiah S Hama DW Garber M Chaddha G Hough R Lallone AM Fogelman, Circulation 2002 105 290 292 10.1161/hc0302.103711 11804981
56. Oral D-4F causes formation of pre- high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice. M Navab GM Anantharamaiah ST Reddy S Hama G Hough VR Grijalva AC Wagner JS Frank G Datta D Garber AM Fogelman, Circulation 2004 109 3215 3220 10.1161/01.CIR.0000134275. 90823.87 15197147
57. Differential effects of apolipoprotein A-1-mimetic peptide on evolving and established atherosclerosis in apolipoprotein E-null mice. X Li K Chyu JR Faria Neto J Yano N Nathwani C Ferreira PC Dimayuga B Cercek S Kaul PK Shah, Circulation 2004 110 1701 1705 10.1161/01.CIR.0000142857.79401.69 15353488 (Pubitemid 39297996)
58. High apolipoproteinB, low apolipoproteinA-I, and improvement in the prediction of fatal myocardial infarction(AMORIS Study):a prospective study. G Walldius I Jungner I Holme AH Aastveit W Kolar E Steiner, Lancet 2001 358 2026 2033 10.1016/S0140-6736(01)07098-2 11755609
59. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTER-GEART study):case-control study. P Yusuf S Hawken S Ounpuu T Dans A Avazeum F Lanas M McQueen A Budaj P Pais J Vargios L Lisheng on behalf of the INTERHEART Study Investigators, Lancet 2004 364 937 952 10.1016/S0140-6736(04)17018-9 15364185
60. The apolipoproteinB/AI ratio and the metabolic syndrome independently predict risk for myocardial infarction in middle-aged men. L Lind B Vessby J Sundstrm, Arterioscler Thromb Vasc Biol 2006 26 406 410 10.1161/01.ATV. 0000197827.12431.d0 16306426
61. ApolipoproteinB/ApolipoproteinAI in relation to the metabolic syndrome and change in carotid artery intima-media thickness during 3 years in middle-aged men. K Wallenfeldt L Bokemark J Wikstrand J Hulthe B Fagerberg, Stroke 2004 35 2248 2252 10.1161/01.STR.0000140629.65145.3c 15345795